NASDAQ:STSA
Satsuma Pharmaceuticals, Inc.
- Stock
Last Close
1.10
07/06 20:00
Market Cap
36.47M
Beta: 0.08
Volume Today
1.83M
Avg: 1.01M
PE Ratio
−0.58
PFCF: −0.74
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 400K - | 2.30M 476.13% | 3.83M 66.26% | 2.42M 36.71% | 1.69M 30.31% | ||
average receivables | |||||||
book value per share | -0.80 - | -3.08 285.35% | -7.33 138.30% | -5.20 29.05% | 3.47 166.76% | -6.61 290.39% | |
capex per share | -0.01 - | -0.10 1,095.86% | -0.09 7.85% | -0.30 215.80% | -0.07 76.55% | -0.01 78.82% | |
capex to depreciation | -5.80 - | -7.05 21.60% | -3.91 44.59% | -21.61 453.02% | -5.17 76.10% | -0.69 86.62% | |
capex to operating cash flow | 0.01 - | 0.06 329.01% | 0.02 67.71% | 0.12 556.35% | 0.05 61.31% | 0.01 80.59% | |
capex to revenue | |||||||
cash per share | 0.24 - | 1.32 441.65% | 18.37 1,291.10% | 3.92 78.65% | 3.19 18.56% | 1.64 48.67% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 0.05 - | 0.78 1,542.27% | 0.04 94.98% | 0.04 4.16% | 0.01 73.72% | 0.00 74.46% | |
debt to equity | -0.02 - | -0.41 2,264.93% | -0.11 71.99% | -0.03 70.80% | 0.01 131.83% | -0.00 106.11% | |
dividend yield | |||||||
earnings yield | -0.04 - | -0.11 145.06% | -0.24 120.33% | -0.59 142.78% | -0.39 34.63% | -2.40 522.40% | |
enterprise value | 113.39M - | 66.39M 41.45% | 97.58M 46.98% | 46.95M 51.89% | 116.53M 148.22% | 12.53M 89.25% | |
enterprise value over ebitda | -22.03 - | -9.22 58.14% | -3.52 61.79% | -0.99 71.78% | -2.30 131.53% | -0.21 90.67% | |
ev to operating cash flow | -26.24 - | -9.51 63.76% | -3.29 65.38% | -1.11 66.31% | -2.71 144.35% | -0.24 91.02% | |
ev to sales | |||||||
free cash flow per share | -0.64 - | -1.87 190.90% | -5.15 174.90% | -2.73 47.00% | -1.54 43.44% | -1.62 5.18% | |
free cash flow yield | -0.04 - | -0.11 190.90% | -0.26 136.07% | -0.59 126.26% | -0.34 42.05% | -1.80 425.91% | |
graham net net | -0.85 - | -3.38 298.77% | 16.50 588.81% | 3.40 79.41% | 2.90 14.59% | 1.39 52.26% | |
graham number | 3.70 - | 11.36 207.30% | 28.09 147.27% | 17.84 36.48% | 11.64 34.73% | 17.93 53.95% | |
income quality | 0.84 - | 0.95 13.75% | 1.05 10.69% | 0.89 15.40% | 0.84 5.58% | 0.74 12.48% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -329.80 - | -83.50 74.68% | -59.92 28.24% | -138.08 130.44% | -313.90 127.33% | -5.46K 1,638.59% | |
interest debt per share | 0.02 - | 1.28 7,901.62% | 0.92 28.02% | 0.19 78.95% | 0.04 78.07% | 0.00 88.93% | |
inventory turnover | |||||||
invested capital | -0.02 - | -0.41 2,264.93% | -0.11 71.99% | -0.03 70.80% | 0.01 131.83% | -0.00 106.11% | |
market cap | 114.96M - | 66.63M 42.04% | 115.40M 73.21% | 80.24M 30.47% | 131.28M 63.61% | 28.82M 78.05% | |
net current asset value | -5.50M - | -13.11M 138.26% | 103.80M 891.85% | 64.69M 37.68% | 91.36M 41.22% | 46.69M 48.89% | |
net debt to ebitda | 0.30 - | 0.03 89.03% | 0.64 1,830.73% | 0.71 9.56% | 0.29 58.66% | 0.28 4.16% | |
net income per share | -0.76 - | -1.86 145.06% | -4.78 156.57% | -2.72 43.13% | -1.73 36.19% | -2.16 24.48% | |
operating cash flow per share | -0.64 - | -1.77 178.75% | -5.05 185.43% | -2.43 51.88% | -1.47 39.39% | -1.61 9.15% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -2.61 - | -1.15 55.84% | -0.22 80.72% | -0.58 163.06% | -0.46 21.09% | -1.26 173.17% | |
revenue per share | |||||||
roe | 0.95 - | 0.61 36.41% | 0.65 7.67% | 0.52 19.85% | -0.50 195.58% | 0.33 165.38% | |
roic | 0.93 - | 1.05 13.14% | 0.75 28.01% | 0.55 27.22% | -0.49 189.95% | 0.33 167.02% | |
sales general and administrative to revenue | |||||||
shareholders equity per share | -0.80 - | -3.08 285.35% | -7.33 138.30% | -5.20 29.05% | 3.47 166.76% | -6.61 290.39% | |
stock based compensation to revenue | |||||||
tangible asset value | -5.43M - | -12.13M 123.34% | 115.33M 1,050.67% | 71.94M 37.63% | 101.34M 40.88% | 46.82M 53.80% | |
tangible book value per share | -0.80 - | -3.08 285.35% | 19.67 739.15% | 4.13 78.99% | 3.47 15.95% | 1.46 57.91% | |
working capital | 214K - | 3.44M 1,507.01% | 106.77M 3,004.77% | 65.74M 38.43% | 91.36M 38.97% | 46.69M 48.89% |
All numbers in USD (except ratios and percentages)